Daclatasvir and sofosbuvir treatment of decompensated liver disease or post-liver transplant hepatitis C virus recurrence in patients with advanced liver disease/cirrhosis in a real-world cohort.

Kwo, Paul; Fried, Michael W; Reddy, K Rajender; Soldevila-Pico, Consuelo; Khemichian, Saro; Darling, Jama; Zamor, Phillippe J; Napoli, Andrew A; Anduze-Faris, Beatrice; Brown, Robert S

Kwo, Paul; Fried, Michael W; Reddy, K Rajender; Soldevila-Pico, Consuelo; Khemichian, Saro; Darling, Jama; Zamor, Phillippe J; Napoli, Andrew A; Anduze-Faris, Beatrice; Brown, Robert S.

Afiliación

Kwo P; Division of Gastroenterology and Hepatology Stanford University School of Medicine Palo Alto CA.
Fried MW; Department of Medicine University of North Carolina School of Medicine Chapel Hill NC.
Reddy KR; Division of Gastroenterology and Hepatology University of Pennsylvania Philadelphia PA.
Soldevila-Pico C; Department of Medicine, College of Medicine University of Florida Gainesville FL.
Khemichian S; Department of Medicine, Keck School of Medicine University of Southern California Los Angeles CA.
Darling J; Department of Medicine University of North Carolina School of Medicine Chapel Hill NC.
Zamor PJ; Division of Hepatology Carolinas Medical Center Charlotte NC.
Napoli AA; Bristol Myers-Squibb Lawrenceville NJ.
Anduze-Faris B; Bristol Myers-Squibb Lawrenceville NJ.
Brown RS; Department of Medicine Weill Cornell Medicine New York NY.

Hepatol Commun ; 2(4): 354-363, 2018 04.

Article en En | MEDLINE | ID: mdl-29619415

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Hepatol Commun Año: 2018 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google